GETI.B

196.25

-0.1%↓

ATT

103.6

+1.17%↑

AMBEA

132.4

+0.38%↑

ARJOB

26.2

+0.23%↑

MSON.B

11.25

+1.35%↑

GETI.B

196.25

-0.1%↓

ATT

103.6

+1.17%↑

AMBEA

132.4

+0.38%↑

ARJOB

26.2

+0.23%↑

MSON.B

11.25

+1.35%↑

GETI.B

196.25

-0.1%↓

ATT

103.6

+1.17%↑

AMBEA

132.4

+0.38%↑

ARJOB

26.2

+0.23%↑

MSON.B

11.25

+1.35%↑

GETI.B

196.25

-0.1%↓

ATT

103.6

+1.17%↑

AMBEA

132.4

+0.38%↑

ARJOB

26.2

+0.23%↑

MSON.B

11.25

+1.35%↑

GETI.B

196.25

-0.1%↓

ATT

103.6

+1.17%↑

AMBEA

132.4

+0.38%↑

ARJOB

26.2

+0.23%↑

MSON.B

11.25

+1.35%↑

Home・Elenco Azioni・Vivesto AB

Vivesto AB

Chiusa

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

Massimo

Metriche Chiave
By Trading Economics
Entrata	-1.9M -9.1M
EPS	-0.013
Dipendenti	4
EBITDA	-1.8M -8.9M

Dividendi
By Dow Jones
Utili prossimi	7 mag 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-124K 51M
Apertura precedente	0
Chiusura precedente	0

Vivesto AB Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

6 mar 2026, 19:32 UTC

Acquisizioni, Fusioni, Takeovers

Diana Shipping Increases Offer to Acquire Genco -- Update

6 mar 2026, 17:44 UTC

Acquisizioni, Fusioni, Takeovers

Lonza to Offload Majority Stake in Capsule Business to Lone Star in $2.2 Billion Deal

6 mar 2026, 22:26 UTC

Principali Notizie su Eventi

Why $100 Oil Is Now in Sight. Who Wins, Who Loses. -- Barrons.com

6 mar 2026, 22:07 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Boeing Says Spirit Acquisition Will Help Improve Safety -- Market Talk

6 mar 2026, 22:03 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

6 mar 2026, 22:03 UTC

Discorsi di Mercato

Boeing CEO's Pay Nears $24 Million During Recovery Phase -- Market Talk

6 mar 2026, 21:50 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Financial Services Roundup: Market Talk

6 mar 2026, 21:37 UTC

Utili

Salesforce Stock Might Not Be an AI Loser After All -- Barrons.com

6 mar 2026, 21:25 UTC

Principali Notizie su Eventi

How The Iran War Impacts Ukraine. -- Barrons.com

6 mar 2026, 21:17 UTC

Utili

Burlington Stores' Strong Year Should Lift the Stock. What Comes Next. -- Barrons.com

6 mar 2026, 20:50 UTC

Utili

Marvell Stock Pops 20%. Semiconductor Earnings Show AI Demand Is Strong. -- Barrons.com

6 mar 2026, 20:46 UTC

Utili

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

6 mar 2026, 20:31 UTC

Principali Notizie su Eventi

Oil Prices Soar Past $90. Trump Demands 'Unconditional Surrender' From Iran -- and Kuwait Cut Production. -- Barrons.com

6 mar 2026, 20:18 UTC

Discorsi di Mercato

Oil Makes Record Weekly Gains As Strait of Hormuz Stays Shut -- Market Talk

6 mar 2026, 20:12 UTC

Discorsi di Mercato

Principali Notizie su Eventi

U.S. Natural Gas Futures Gain on Global Energy Turmoil -- Market Talk

6 mar 2026, 19:10 UTC

Discorsi di Mercato

Principali Notizie su Eventi

$150 Oil Seen As Realistic If Hormuz Closure Lasts -- Market Talk

6 mar 2026, 18:54 UTC

Discorsi di Mercato

Fed's Hammack: Dollar Hasn't Lost Prime Status -- Market Talk

6 mar 2026, 18:44 UTC

Discorsi di Mercato

Principali Notizie su Eventi

U.S. Oil Rig Count Increases By 4 to 411 -- Market Talk

6 mar 2026, 18:08 UTC

Utili

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

6 mar 2026, 18:04 UTC

Utili

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

6 mar 2026, 18:04 UTC

Utili

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

6 mar 2026, 17:49 UTC

Discorsi di Mercato

AI-Driven Picks-And-Shovels Bet Comes With Risks -- Market Talk

6 mar 2026, 17:46 UTC

Principali Notizie su Eventi

Kuwait Cuts Oil Production as Fallout From Iran Conflict Intensifies -- Update

6 mar 2026, 17:40 UTC

Discorsi di Mercato

Utili

Marvell's Long-Term Outlook Well-Received By Investors -- Market Talk

6 mar 2026, 17:40 UTC

Utili

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

6 mar 2026, 17:32 UTC

Discorsi di Mercato

Principali Notizie su Eventi

No Quick Solution for Hormuz Shipping as U.S. Oil Tops $90 -- Market Talk

6 mar 2026, 17:28 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Aluminum Rising as Strait of Hormuz Stays Locked -- Market Talk

6 mar 2026, 17:20 UTC

Discorsi di Mercato

Utili

Auto & Transport Roundup: Market Talk

6 mar 2026, 17:20 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Basic Materials Roundup: Market Talk

6 mar 2026, 17:20 UTC

Acquisizioni, Fusioni, Takeovers

BlackRock Sticks to Redemption Minimum on Credit Fund, Sends Shares Lower -- WSJ

Confronto tra pari

Modifica del prezzo

Vivesto AB Previsione

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.